Patrick Nachman is a Nephrology physician affiliated with University of Minnesota. OpenAlex indexes 20 publications with 503 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
909 Fulton St SE
Minneapolis, MN 554554800
Telephone
612-672-7422Registry record last updated 21 Nov 2017.
Clinical trials
- Belimumab With Rituximab for Primary Membranous Nephropathy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
Sponsor: University of North Carolina, Chapel Hill
- Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
Sponsor: University of North Carolina, Chapel Hill
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20251 payment
- Calliditas Therapeutics US Inc.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.7%Angiotensin receptor blocker (ARB)21.9%Losartan Potassium100%Part D<11 patientsLoop diuretic16.2%Furosemide100%Part D<11 patients+ 4 more classes in this area
Anti-infectives
13.3%Short-acting sulfonamides13.3%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics
University of Minnesota
FY2026$452,262U01DK133097 - Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics
University of Minnesota
FY2025$499,999U01DK133097 - Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics
University of Minnesota
FY2024$100,000U01DK133097
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Serum Sodium Variation Associated with Increased Mortality in Hospitalized Patients with Moderate to Severe Hyponatremia
Journal of the American Society of Nephrology
2025 - Predictors of 24-Hour Sodium Correction in Moderate to Severe Hyponatremia
Journal of the American Society of Nephrology
2025 - High Burden of Adverse Pregnancy Outcomes in Alport Syndrome: Insights from a US National Patient Survey
Journal of the American Society of Nephrology
2025 - Innovating and invigorating the clinical trial infrastructure for glomerular diseases
Kidney International
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Blazar, MD
University of Minnesota
Jay Cohn, MD
University of Minnesota
Julia Steinberger, MD
University of Minnesota
Charles Herzog, MD
University of Minnesota
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”